ArticlemBio2026
Mice on a high-fat diet have reduced immunopathology and an altered immune response during respiratory syncytial virus infection.
Article in mBio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Obesity has been identified as an independent risk factor for increased morbidity and mortality during pandemic H1N1 influenza and SARS-CoV-2 infections. Various studies have determined that obese hosts have dysregulated antiviral responses driven by systemic low-grade inflammation, resulting in prolonged viral replication, induction of proinflammatory cytokines during the disease resolution phase, and profound lung parenchymal damage. However, the impact of obesity on disease outcomes in the context of other viral respiratory infections remains unclear. In this study, we sought to understand how obesity affects disease progression during respiratory syncytial virus (RSV) infection using an obese mouse model in which male C57BL/6 mice were fed a high-fat diet (HFD). Mice fed a standard chow diet served as controls. We found that HFD mice exhibited reduced weight loss, illness scores, and histopathological changes after intranasal inoculation with RSV A2. Investigation of potential mechanisms underlying this reduction in severity revealed reduced viral load in obese mice, along with altered innate and adaptive immune responses. Specifically, HFD mice had reduced proinflammatory cytokines in the lungs early in infection and increased CD4 IMPORTANCE: Obesity has been shown to induce dysregulated antiviral responses during influenza infections, resulting in extensive morbidity and mortality. No studies to date have investigated how obesity-induced immune dysregulation affects respiratory syncytial virus (RSV) disease progression. RSV has a high global burden, inflicting millions of infections and tens of thousands of deaths yearly, most notably among the very young, the elderly, and those with comorbidities. It is essential to understand how risk factors, such as obesity, affect disease progression to ensure appropriate protection and care for patients. Here, we demonstrate that male C57BL/6 mice fed a high-fat diet had lower viral loads and attenuated inflammatory responses during RSV infection, resulting in reduced morbidity and immunopathology. This pilot study advances our understanding of how obesity affects pulmonary antiviral immunity to RSV and, concurrently, further elucidates RSV pathogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.